ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Episodes
The Feel Trial: Spirituality Intervention on Blood Pressure Control, Central Hemodynamics and Endothelial Function
06 Aug 2024
Contributed by Lukas
Incorporating spiritual evaluation into medical science is worth consideration. The presence of edifying emotions can potentially yield positive effe...
Eat Food, Not Too Much, Mostly Plants: Nutrition and CVD
23 Jul 2024
Contributed by Lukas
If there were a pill that could lower blood pressure, lower LDL cholesterol, improve erectile function and lower cardiovascular risk, would you take ...
Hypertrophic Cardiomyopathy (HCM): Selecting the Right Meds and Procedures
16 Jul 2024
Contributed by Lukas
Hypertrophic cardiomyopathy (HOCM) often goes unnoticed, yet as awareness grows, patients may find themselves more symptomatic than expected. How do ...
Hypertrophic Cardiomyopathy (HCM): Selecting the Right Meds and Procedures
16 Jul 2024
Contributed by Lukas
Hypertrophic cardiomyopathy (HOCM) often goes unnoticed, yet as awareness grows, patients may find themselves more symptomatic than expected. How do ...
PVC Burden and Its Temporal Variability: 24/48 Hours or Longer Monitoring?
09 Jul 2024
Contributed by Lukas
Premature ventricular contractions (PVCs), commonly experienced as palpitations from occasional skipped heartbeats, are typically benign but can esca...
Financial Incentives to Improve Cardiac Rehab Participation
02 Jul 2024
Contributed by Lukas
Individuals from lower socioeconomic status (SES) backgrounds face heightened risks of morbidity and mortality, particularly in the context of health...
Inpatient Initiation of HF GDMT: What Are You Waiting For?
25 Jun 2024
Contributed by Lukas
In this interview, Stephen Greene, MD, FACC and Sidney C. Smith Jr., MD, MACC discuss inpatient initiation of HF GDMT. Subscribe on Apple Podc...
Plaque Burden, Morphology and Flow – Beyond the Lumen
18 Jun 2024
Contributed by Lukas
Why should we assess plaque burden beyond luminal narrowing for cardiac prevention? In this interview, Andrew Choi, MD, FACC and Clyde W. Yan...
Plaque Burden, Morphology and Flow – Beyond the Lumen
18 Jun 2024
Contributed by Lukas
Why should we assess plaque burden beyond luminal narrowing for cardiac prevention? In this interview, Andrew Choi, MD, FACC and Clyde W. Yan...
Natural History of Bicuspid and Aneurysm-Associated Aortic Valve Disease
11 Jun 2024
Contributed by Lukas
The most common congenital heart defect, congenital BAV, affects 1% of the population (2% in men, 0.5% in women), with a male-to-female ratio of 2:1 ...
Hey Doc, There's Calcium In My Coronaries⋯ Now What?
04 Jun 2024
Contributed by Lukas
Discover how detection of coronary artery calcium can greatly enhance risk prediction and risk mitigation, making it a critical tool for clinicians a...
The Hormone Puzzle: Decoding the what, when and how long of hormone replacement therapy in women
28 May 2024
Contributed by Lukas
In this interview, Leslie Cho, MD, FACC, and Steven E. Nissen MD, MACC explore the nuances of estrogen and testosterone replacement: who benefits, wh...
Ultimate DAPT Trial Principal Results - Ticagrelor monotherapy following one month of dual antiplatelet therapy (DAPT) outperforms 12-month DAPT (aspirin and ticagrelor) post PCI for reducing clinically meaningful bleeding
21 May 2024
Contributed by Lukas
Ticagrelor monotherapy following one month of dual antiplatelet therapy (DAPT) outperforms 12-month DAPT (aspirin and ticagrelor) post PCI for reducin...
Be Active RCT: Gamification & Financial Incentives to Increase Physical Activity
14 May 2024
Contributed by Lukas
The Be Active trial demonstrates the efficacy of scalable interventions, incorporating remote monitoring and behavioral economics, in boosting physic...
Statin Intolerance, Inclisarin, and the VICTORION-INITIATE Trial
07 May 2024
Contributed by Lukas
The VICTORION-INIATATE study demonstrated that initiating inclisiran, a highly potent lipid-lowering therapy, upon failure to achieve lipid targets w...
ARISE-HF Primary Results: Selective Aldose Reductase Inhibitor For Diabetic Cardiomyopathy
23 Apr 2024
Contributed by Lukas
Heart failure is an increasingly recognized complication in chronic diabetes that may be caused by a number of processes including direct effects of ...
The Future of Cardiology - Value-Based Care, Private Equity and the Practice Landscape
16 Apr 2024
Contributed by Lukas
It's becoming increasingly evident that alongside top-notch clinical expertise, the CV specialist of the future must be surrounded by a multi-talente...
EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction
09 Apr 2024
Contributed by Lukas
Patients with acute myocardial infarction are at a high risk of heart failure and death. Despite advances in care and reduction in the rate of recurr...
From JACC: HFpEF: Practical Guidance for Clinicians
02 Apr 2024
Contributed by Lukas
About half of patients with chronic heart failure have an ejection fraction 40%. Therapy for patients in this group has been challenging until recent...
From JACC: Aortic Valve Calcium and the Long-Term Risk of Incident Severe AS
26 Mar 2024
Contributed by Lukas
Aortic valve disease is often identified too late before clinicans can provide meaningful prevention. Identifying aortic valve calcium opens the ...
From JACC: Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare Beneficiaries
19 Mar 2024
Contributed by Lukas
After a heart attack, it is important to lower cholesterol levels to prevent future heart attacks. Monitoring cholesterol levels on treatment is just...
JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery
12 Mar 2024
Contributed by Lukas
This episode covers a review on disparities in cardiovascular perioperative health care. The writers propose actionable solutions utilizing multidisc...
From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs
05 Mar 2024
Contributed by Lukas
Cardiac imaging is increasingly used in the workup of coronary artery disease, with growth greatest for CCTA and with falling use of SPECT. Because o...
ACCEL Lite: Top Takeaways from the AFib Guidelines
29 Feb 2024
Contributed by Lukas
In this interview, José A. Joglar, MD, FACC, and Joseph E. Marine MD, MBA, FACC, discuss the top takeaways from the latest atrial fibrillation (AFib...
ACCEL Lite: From JACC: Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death
27 Feb 2024
Contributed by Lukas
A study provides new data for patients with genetic heart disease (GHD) and exercise recommendations. For decades, those with GHD were excluded from ...
AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AF
20 Feb 2024
Contributed by Lukas
Continuous cardiac monitoring detects brief, asymptomatic, heart rhythm abnormalities in one-third of older individuals and these symptoms are associ...
ACCEL Lite: Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies
15 Feb 2024
Contributed by Lukas
The 2023 guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering soc...
ACCEL Lite: Top Takeaways from the ACC 2023 Guideline for Chronic CAD for the Practicing Clinician
13 Feb 2024
Contributed by Lukas
To improve our understanding of the basic principles in the treatment and management of patients with chronic heart disease, in this interview, Salim...
ACCEL Lite: Management of Worsening Heart Failure with Reduced Ejection Fraction
06 Feb 2024
Contributed by Lukas
Patients with worsening heart failure are at an extraordinarily high risk for mortality and readmission. Early identification and optimal management ...
ACCEL Lite: AHA Late-Breaker: SELECT – Semaglutide and CV Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes
23 Jan 2024
Contributed by Lukas
The SELECT trial extends findings from previous trials, which demonstrated cardiovascular benefit in diabetes mellitus (DM), to those without DM. In ...
ACCEL Lite: From JACC: Managing Patients with Moderate Aortic Stenosis
16 Jan 2024
Contributed by Lukas
In this review, authors discuss how multimodality imaging can help to evaluate the left ventricular remodeling response and improve risk stratificati...